Invitrogen™ Human IFN beta Synthetic Peptide

Ref.: BL-RE-176370Manufacturer ref.: PEP0507 50 μg
€173.00 excl. VAT

IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.

Gene ID (Enter)
3456
Species
Human
Purification method
Purified
Accession number
P01574
Common name
Human IFN beta
Brand
Invitrogen

IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.

IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.

Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 1 mg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15368620
Specifications
Gene ID (Enter)3456
SpeciesHuman
Purification methodPurified
Accession numberP01574
Common nameHuman IFN beta
Concentration1 mg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)IFNB1
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP0507
Country of originUnited States
HS customs code2934 99 90 00
A question or a specific configuration?
Contact us for a quote.